ERBB2 and breast cancer: To assess the diagnostic potential of blood exosomes and evaluate the contribution of endotheliocytes to the blood exosome proteome, we performed a differential analysis of exosomal proteomes from primary endotheliocytes, from two cell lines mimicking luminal A and luminal Her2-positive BC, and from the blood of patients with these BC subtypes.